Sarepta Therapeutics (SRPT) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Sarepta Therapeutics Revenue Highlights


Latest Revenue (Y)

$1.24B

Latest Revenue (Q)

$362.93M

Main Geography (Y)

UNITED STATES

Sarepta Therapeutics Revenue by Period


Sarepta Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$1.24B33.26%
2022-12-31$933.01M32.93%
2021-12-31$701.89M29.96%
2020-12-31$540.10M41.82%
2019-12-31$380.83M26.51%
2018-12-31$301.03M94.74%
2017-12-31$154.58M2751.58%
2016-12-31$5.42M332.64%
2015-12-31$1.25M-87.16%
2014-12-31$9.76M-31.38%
2013-12-31$14.22M-61.91%
2012-12-31$37.33M-20.56%
2011-12-31$46.99M59.72%
2010-12-31$29.42M67.30%
2009-12-31$17.59M-17.28%
2008-12-31$21.26M93.52%
2007-12-31$10.99M9428.23%
2006-12-31$115.29K-97.59%
2005-12-31$4.78M1011.31%
2004-12-31$430.46K-55.62%
2003-12-31$969.87K15.90%
2002-12-31$836.78K18.51%
2001-12-31$706.10K-45.57%
2000-12-31$1.30M1197.34%
1999-12-31$100.00K-50.00%
1998-12-31$200.00K100.00%
1997-12-31$100.00K-
1996-12-31$100.00K-
1995-12-31$100.00K-

Sarepta Therapeutics generated $1.24B in revenue during NA 2023, up 33.26% compared to the previous quarter, and up 413.02% compared to the same period a year ago.

Sarepta Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$362.93M-12.22%
2024-03-31$413.46M4.20%
2023-12-31$396.78M19.58%
2023-09-30$331.82M27.02%
2023-06-30$261.24M3.05%
2023-03-31$253.50M-1.91%
2022-12-31$258.43M12.23%
2022-09-30$230.27M-1.38%
2022-06-30$233.49M10.75%
2022-03-31$210.83M4.65%
2021-12-31$201.46M6.36%
2021-09-30$189.41M15.43%
2021-06-30$164.09M11.68%
2021-03-31$146.93M1.24%
2020-12-31$145.14M0.84%
2020-09-30$143.92M4.78%
2020-06-30$137.36M20.84%
2020-03-31$113.67M13.55%
2019-12-31$100.11M1.08%
2019-09-30$99.04M4.62%
2019-06-30$94.67M8.80%
2019-03-31$87.01M3.08%
2018-12-31$84.42M7.55%
2018-09-30$78.49M6.74%
2018-06-30$73.53M13.81%
2018-03-31$64.60M12.79%
2017-12-31$57.28M24.64%
2017-09-30$45.95M31.26%
2017-06-30$35.01M114.24%
2017-03-31$16.34M201.46%
2016-12-31$5.42M100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--100.00%
2015-12-31$1.25M100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31--100.00%
2014-12-31$27.00K-97.45%
2014-09-30$1.06M-59.00%
2014-06-30$2.58M-57.57%
2014-03-31$6.09M131.84%
2013-12-31$2.63M-37.00%
2013-09-30$4.17M41.24%
2013-06-30$2.95M-34.04%
2013-03-31$4.47M-39.01%
2012-12-31$7.34M-3.14%
2012-09-30$7.57M-32.42%
2012-06-30$11.21M-0.04%
2012-03-31$11.21M-17.47%
2011-12-31$13.59M80.56%
2011-09-30$7.52M-35.05%
2011-06-30$11.59M-18.96%
2011-03-31$14.30M-7.87%
2010-12-31$15.52M78.32%
2010-09-30$8.70M117.71%
2010-06-30$4.00M231.70%
2010-03-31$1.21M-76.56%
2009-12-31$5.14M-19.03%
2009-09-30$6.35M115.59%
2009-06-30$2.94M-6.51%
2009-03-31$3.15M-42.52%
2008-12-31$5.48M5.98%
2008-09-30$5.17M3.77%
2008-06-30$4.98M-11.41%
2008-03-31$5.62M8.45%
2007-12-31$5.19M-

Sarepta Therapeutics generated $362.93M in revenue during Q2 2024, up -12.22% compared to the previous quarter, and up 143.17% compared to the same period a year ago.

Sarepta Therapeutics Revenue Breakdown


Sarepta Therapeutics Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 21Jun 21Mar 21
V Y O N D Y S Fifty Three$24.66M$22.44M$17.55M
A M O N D Y S Fourty Five$26.66M$6.94M$193.00K
E X O N D Y S Fifty One$115.60M$112.46M$107.19M

Sarepta Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: E X O N D Y S Fifty One (69.26%), A M O N D Y S Fourty Five (15.97%), and V Y O N D Y S Fifty Three (14.77%).

Sarepta Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
UNITED STATES$797.94M$747.10M
Rest of World$146.58M-
Non-US-$96.70M

Sarepta Therapeutics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (84.48%), and Rest of World (15.52%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23
Rest of World$38.10M$35.88M$104.43M$42.15M--
UNITED STATES$210.68M$189.67M$195.47M$198.07M$203.90M$200.50M
Non-US----$35.10M$31.00M

Sarepta Therapeutics's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (84.68%), and Rest of World (15.32%).

Sarepta Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SRPTSarepta Therapeutics$1.24B$362.93M
PTCTPTC Therapeutics$937.82M$135.42M
KRYSKrystal Biotech$50.70M$83.84M
IOVAIovance Biotherapeutics$1.19M$58.55M
VKTXViking Therapeutics--
MDGLMadrigal Pharmaceuticals-$62.17M
TERNTerns Pharmaceuticals--
AKROAkero Therapeutics--
HEPAHepion Pharmaceuticals--

SRPT Revenue FAQ


What is Sarepta Therapeutics’s yearly revenue?

Sarepta Therapeutics's yearly revenue for 2023 was $1.24B, representing an increase of 33.26% compared to 2022. The company's yearly revenue for 2022 was $933.01M, representing an increase of 32.93% compared to 2021. SRPT's yearly revenue for 2021 was $701.89M, representing an increase of 29.96% compared to 2020.

What is Sarepta Therapeutics’s quarterly revenue?

Sarepta Therapeutics's quarterly revenue for Q2 2024 was $362.93M, a -12.22% decrease from the previous quarter (Q1 2024), and a 38.93% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $413.46M, a 4.20% increase from the previous quarter (Q4 2023), and a 63.10% increase year-over-year (Q1 2023). SRPT's quarterly revenue for Q4 2023 was $396.78M, a 19.58% increase from the previous quarter (Q3 2023), and a 53.54% increase year-over-year (Q4 2022).

What is Sarepta Therapeutics’s revenue growth rate?

Sarepta Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 77.14%, and for the last 5 years (2019-2023) was 226.48%.